Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

07 janv. 2026 18h02 HE | Source: Hagens Berman Sobol Shapiro LLP

Telix (TLX) 2-DAY DEADLINE ALERT: Hagens Berman Urges Telix Investors to Act by Jan. 9 in Class Action Suit Over SEC Subpoena & FDA CRL on Manufacturing Failures

Investors who lost money in TLX after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
05 janv. 2026 09h09 HE | Source: Hagens Berman Sobol Shapiro LLP

Telix (TLX) 4-DAY DEADLINE ALERT: Hagens Berman Urges Telix Investors to Act by Jan. 9 in Class Action Suit Over SEC Subpoena & FDA CRL on Manufacturing Failures

Investors who lost money in TLX after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
04 janv. 2026 12h00 HE | Source: Hagens Berman Sobol Shapiro LLP

TLX 5-DAY DEADLINE ALERT: Hagens Berman Urges Telix Investors to Act by Jan. 9 in Class Action Suit Over SEC Subpoena & FDA CRL on Manufacturing Failures

SAN FRANCISCO, Jan. 04, 2026 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman is issuing a reminder to investors in Telix Pharmaceuticals Ltd. (NASDAQ: TLX) that the deadline...
02 janv. 2026 14h24 HE | Source: Hagens Berman Sobol Shapiro LLP

TLX 7-DAY DEADLINE ALERT: Hagens Berman Urges Telix Investors to Act by Jan. 9 Over Alleged Dual Regulatory Failures: SEC Subpoena & FDA CRL on CMC/Supply Chain

SAN FRANCISCO, Jan. 02, 2026 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman is issuing a reminder to investors in Telix Pharmaceuticals Ltd. (NASDAQ: TLX) that the deadline...
31 déc. 2025 14h01 HE | Source: Hagens Berman Sobol Shapiro LLP

TLX CLASS ACTION DEADLINE: Hagens Berman Urges Telix Investors to Act by Jan. 9 Over Alleged Dual Regulatory Failures: SEC Subpoena & FDA CRL on CMC/Supply Chain

SAN FRANCISCO, Dec. 31, 2025 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman is issuing a reminder to investors in Telix Pharmaceuticals Ltd. (NASDAQ: TLX) that the deadline...
29 déc. 2025 16h48 HE | Source: Hagens Berman Sobol Shapiro LLP

TLX 11-DAY DEADLINE ALERT: Hagens Berman Urges Telix (TLX) Investors to Act by Jan. 9 Over Alleged Dual Regulatory Failures: SEC Subpoena & FDA CRL on CMC/Supply Chain

Investors who lost money in TLX after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
25 déc. 2025 12h00 HE | Source: Hagens Berman Sobol Shapiro LLP

TLX CLASS ACTION DEADLINE: Hagens Berman Urges Telix Investors to Act by Jan. 9 Over Alleged Dual Regulatory Failures: SEC Subpoena & FDA CRL on CMC/Supply Chain

Investors who lost money in TLX after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
18 déc. 2025 10h50 HE | Source: Hagens Berman Sobol Shapiro LLP

21% TLX PLUNGE: Hagens Berman Urges Telix Investors to Act by Jan. 9 in Class Action Suit Over SEC Subpoena & FDA CRL on Manufacturing Failures

Investors who lost money in TLX after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
16 déc. 2025 18h54 HE | Source: Hagens Berman Sobol Shapiro LLP

21% TLX PLUNGE: Hagens Berman Urges Telix Investors to Act by Jan. 9 in Class Action Suit Over SEC Subpoena & FDA CRL on Manufacturing Failures

Investors who lost money in TLX after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.